Annotated Medicine and Device Lists


Suriname. NGK-C-011

01. Anesthetics
02. Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory Agents, Anti-Gout Agents and Agents for Rheumatic Diseases
03. Anti-Allergics and Medicines for Anaphylaxis
04. Antidotes and other agents for poisoning
05. Anti-Convulsants/ Anti-Epileptics
06. Anti-infective agents
07. Anti-Migraine Agents
    7.1 Medications for Acute Attacks 7.2 Medications for Prophylaxis
      Medicine Pharmaceutical form type Composition Observation
      propranolol Tablet 40 mg (hydrochloride)
08. Anti-Neoplastic and Immunosuppressive Agents
09. Medications for Parkinson's Disease
10. Agents that work on the blood
11. Blood Products and Plasma Substitutes
12. Cardiovascular Agents
13. Dermatological preparations
14. Diagnostics
15. Dermatological Preparations
16. Diuretics
17. Agents for the Gastrointestinal Tract
18. Hormones, Other Endocrine Agents and Contraceptives
19. Immunological Agents
20. Muscle Relaxants and Cholinesterase Inhibitors
21. Agents for Eye Diseases
    21.1 Anti-Infection Agents
      Medicine Pharmaceutical form type Composition Observation
      aciclovir Eye ointment 3%
      gentamicin Eye ointment (sulfate) 0.5%
      gentamicin Solution (eye drops) 0.3% (sulfate)
      tetracycline Eye ointment 1% (hydrochloride)
    21.2 Anti-Inflammatory Drugs
      Medicine Pharmaceutical form type Composition Observation
      dexamethasone Solution (eye drops) 0.1%
      prednisolone Eye ointment 0.5% (5mg/g)
    21.3 Decongestants
      Medicine Pharmaceutical form type Composition Observation
      phenylephrine Solution (eye drops) 1.25mg/ml (5ml) (hydrochloride)
    21.4 Local Anesthetics
      Medicine Pharmaceutical form type Composition Observation
      lidocaine Solution (eye drops) 4%
    21.5 Miotics and agents in Glaucoma 21.6 Mydriatic 21.7 Other Eye Agents
      Medicine Pharmaceutical form type Composition Observation
      carbomer Eye gel 3 mg/mL (0.03%)
      diclofenac Solution (eye drops) 0.1%
      hypromellose Solution (eye drops) 0.3%
22. Remedies for throat, nose and ear disorders
23. Oxytocics and Anti-Oxytocics
    23.1 Oxytocics
      Medicine Pharmaceutical form type Composition Observation
      ergometrine Injection 0.2 mg/mL (maleate) in 1-mL ampoule
      misoprostol Tablet 200 mcg
      oxytocin Injection 10 IU in 1-mL ampoule
    23.2 Anti-Oxytocics
      Medicine Pharmaceutical form type Composition Observation
      nifedipine Tablet 20 mg
24. Parenteral Nutrients
25. Psychopharmaceuticals
26. Medicines for Airway and Respiration
    26.1 Medicines for Asthma and COPD
      Medicine Pharmaceutical form type Composition Observation
      beclometasone Inhalation (aerosol) 100 micrograms (dipropionate) per dose (as CFC free forms)
      ipratropium bromide Inhalation (aerosol) 20 micrograms/metered dose
      salbutamol Inhalation (aerosol) 100 mcg (as sulfate) per dose
      salbutamol Injection 1 mg/ mL - 5 mL
      salbutamol Oral liquid 2 mg/5 mL
      salbutamol respirator solution for use in nebulizers 5 mg (as sulfate)/mL
      theophylline Tablet 175 mg
      theophylline Tablet 350 mg
    26.2 Agents of Cough 26.3 Substances effective for the respiratory center of premature babies
      Medicine Pharmaceutical form type Composition Observation
      caffeine citrate Injection 20 mg/ml (equivalent to 10 mg caffeine base/ml)
      caffeine citrate Oral liquid 20 mg/ml (equivalent to 10 mg caffeine base/ml)
27. Agents for Correcting Water, Electrolyte and Acid/Base Disorders
28. Vitamins and Minerals
29. Special Essential Medicines